WOUND HEALING

27

58. Welter H, Bollwein H, Einspanier R: Direct submission to GenBank (AJ439891) for Equus caballus FGF-7, 2002
59. Heldin CH, Westermark B: Role of platelet-derived growth factor in vivo. In RAF Clark ed. The molecular and cellular

biology of wound repair (2nd edition). New York: Plenum Press, 1996, p. 249

60. Donnelly BP, Nixon AJ, Haupt JL, et al: Nucleotide structure of equine platelet-derived growth factor-A and -B and

expression in horses with induced acute tendinitis. Am J Vet Res 2006;67:1218

61. Santoro MM and Gaudino G: Cellular and molecular facets of keratinocyte reepithelialization during wound healing.

Exp Cell Res 2005;304:274

62. Pierce GF, Vande Berg J, Rudolph R, et al: Platelet-derived growth factor-BB and transforming growth factor beta 1

selectively modulate glycosaminoglycans, collagen, and myofi broblasts in excisional wounds. Am J Pathol
1991;138:629

63. Haber M, Cao Z, Panjwani N, et al: Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epi-

thelial cells and keratocytes: implications for wound healing. Vet Ophthalmol 2003;6:211

64. Saba AA, Freedman BM, Gaffi eld JW, et al: Topical platelet-derived growth factor enhances wound closure in the

absence of wound contraction: an experimental and clinical study. Ann Plast Surg 2002;49:62

65. Roberts AB, Sporn MB: Transforming growth factor-

β. In RAF Clark ed. The molecular and cellular biology of wound repair

(2nd edition). New York: Plenum Press, 1996, p. 275

66. Penha-Goncalves MN, Onions DE, Nicolson L: Cloning and sequencing of equine transforming growth factor–beta-1

(TGF–beta-1) cDNA. DNA Seq 1997;7:375

67. Shah M, Foreman DM, Ferguson MWJ: Neutralization of TGF-

β1 and TGF-β2 or exogenous addition of TGF-β3 to

cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985

68. Desmoulière A, Geinoz A, Gabbiani F, et al: Transforming growth factor

β1 induces α-smooth muscle actin expression

in granulation tissue myofi broblasts in quiescent and growing cultured fi broblasts. J Cell Biol 1993;122:103

69. Dvorak HF, Brown LF, Betmar M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular

hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029

70. Howdieshell TR, Callaway D, Webb WL, et al: Antibody neutralization of vascular endothelial growth factor inhibits

wound granulation tissue formation. J Surg Res 2001;96:173

71. Wilgus TA, Matthies AM, Radek KA, et al: Novel function for vascular endothelial growth factor receptor-1 on epider-

mal keratinocytes. Am J Pathol 2005;167:1257

72. Miura N, Misumi K, Kawahara K, et al: Cloning of cDNA and high-level expression of equine vascular endothelial

growth factor. Direct submission to GenBank (AB053350), 2001

73. Woo SLY, Debski RE, Zeminski J, et al: Injury and repair of ligaments and tendons. Ann Rev Biomed Engin 2000;

2:83

74. Frank CB, Hart DA, Shrive NG: Molecular biology and biomechanics of normal and healing ligaments: a review.

Osteoarthr Cartil 1999;7:130

75. Fenwick SA, Hazleman BL, Riley GP: The vasculature and its role in the damaged and healing tendon. Arthritis Res

2002;4:252

76. Gelberman RH: Flexor tendon physiology: tendon nutrition and cellular activity in injury and repair. Instr Course Lect

1985;34:351

77. Tozer S, Duprez D: Tendon and ligament: development, repair and disease. Birth Defects Res C Embryo Today

2005;75:226

78. Dahlgren LA, Mohammed HO, Nixon AJ: Temporal expression of growth factors and matrix molecules in healing

tendon lesions. J Orthop Res 2005;23:84

79. Watkins JP, Auer JA, Gay S, et al: Healing of surgically created defects in the equine superfi cial digital fl exor tendon:

collagen-type transformation and tissue morphologic reorganization. Am J Vet Res 1985;46:2091

80. Manske PR, Gelberman RH, Vande Berg JS, et al: Intrinsic fl exor tendon repair. A morphological study in vitro. J Bone

Joint Surg 1984;66:385

81. Shrive N, Chimich D, Marchuk L, et al: Soft tissue “fl aws” are associated with the material properties of the healing

rabbit medial collateral ligament. J Orthop Res 1995;13:923

82. Frank CB, Shrive NG, McDonald DB, et al: Rabbit medial collateral ligament scar weakness is associated with decreased

collagen hydroxypyridinium cross-link density. J Orthop Res 1995;13:157

83. Frank CB, McDonald D, Shrive NG: Collagen fi bril diameters in the rabbit medial collateral ligament scar: a longer

term assessment. Connect Tissue Res 1997;36:261

84. Dahlgren LA, van der Meulen MC, Bertram JE, et al: Insulin-like growth factor-I improves cellular and molecular

aspects of healing in a collagenase-induced model of fl exor tendinitis. J Orthop Res 2002;20:910

85. Haupt JL, Donnelly BP, Nixon AJ: Effects of platelet-derived growth factor-BB on the metabolic function and morpho-

logic features of equine tendon in explant culture. Am J Vet Res 2006;67:1595

86. Schnabel LV, Mohammed HO, Miller BJ, et al: Platelet-rich plasma (PRP) enhances anabolic gene expression patterns

in fl exor digitorum superfi cialis tendons. J Orthop Res 2007;25:230

87. Pietrzak WS, Eppley BL: Platelet rich plasma: biology and new technology. J Craniofac Surg 2005;16:1043